Contact
Please use this form to send email to PR contact of this press release:
AB Science announces issuance of a Canadian patent for masitinib in the treatment of ALS with protection until 2037
TO:
Please use this form to send email to PR contact of this press release:
AB Science announces issuance of a Canadian patent for masitinib in the treatment of ALS with protection until 2037
TO: